-The Times of India Finance minister P Chidambaram may have brushed aside the Gujarat model of development but the Centre will now have to comment on the efficacy of the model set up by BJP-ruled Chhattisgarh in implementing targeted public distribution system providing subsidized food grains to the poor. The Supreme Court on Monday sought the Centre's comment on the Raman Singh government's model of TPDS implementation, which was repeatedly cited by...
More »SEARCH RESULT
Total Matching Records found : 2490
US to give 'Women of Courage Award' to Delhi gangrape victim
-PTI Washington: United States has selected the 23-year-old Delhi gangrape victim for the International Women of Courage Award. The award would be presented posthumously by the First Lady Michelle Obama and the Secretary of State John Kerry, on March 8, an official announcement said yesterday. "For millions of Indian women, her personal ordeal, perseverance to fight for justice, and her family's continued bravery is helping to lift the stigma and vulnerability that drive...
More »Delhi gangrape victim: Who is the US govt to award her? -Pallavi Polanki
-First Post The national secretary of the All India Progressive Women’s Association (AIPWA), Kavita Krishnan, who was among the leading voices in the public protests that erupted following the gang-rape of 23-year-old student in Delhi has questioned the authority of the US Government in handing out international awards to women fighting against sexual violence. Krishnan’s reaction is in response to the US government’s announcement on March 4, naming the Delhi gang-rape victim...
More »Bayer plea dismissed, Natco allowed to sell patent cancer drug
-The Business Standard Chennai: The Intellectual Property Appellate Board (IPAB) today upheld a compulsory licence issued by the Controller of Patents to Hyderabad-based Natco Pharma Ltd, a generic drug maker, to manufacture and sell a cancer drug of Bayer Corp in India. IPAB, however, made changes in the licence order by increasing the royalty payment to Bayer Corp for Nexavar, used to treat liver and kidney cancer, from six per cent to...
More »Natco Pharma wins cancer drug case-R Sivaraman
-The Hindu Bayer's plea dismissed by the Intellectual Property Appellate Board The Intellectual Property Appellate Board (IPAB) on Monday upheld the grant of compulsory licence (CL) to the Hyderabad-based Natco Pharma Limited, a generic drug maker, to produce and market Nexavar, a patented cancer drug of multinational pharma major Bayer Corporation. The order will pave the way for reduction in the prices of costly life saving drugs. Disposing an appeal filed by Bayer...
More »
